CLOs on the Move

El Rio Community Health Center

www.elrio.org

 
Since 1970, the El Rio Community Health Center has been working to provide quality, accessible health care. Today, more than 76,000 people in the Tucson community rely on the non-profit health center as their primary source of medical and dental care. The El Rio staffs serve over 900 people per day, 76% of those served live at or below the federal poverty level. Dedicated to serving all populations including the underrepresented and uninsured, El Rio has become one of the largest non-profit, community health centers in the United States. Today, over 70,000 people access El Rio for medical and dental care. We ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.elrio.org
  • 839 W. Congress St.
    Tucson, AZ USA 85745
  • Phone: 520.670.3909

Executives

Name Title Contact Details

Similar Companies

Ryogen

Ryogen is a Suffern, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AbboMax

AbboMax is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Neuralstem

Neuralstem is a dual platform regenerative medicine company. The company`s technology enables the production of regionally specific, physiologically relevant neural stem cells for therapeutic use for the treatment of central nervous system (CNS) diseases and has enabled the discovery of a library of patented small molecule neurogenic compounds to treat psychological and cognitive disorders. Neuralstem`s small molecule drug discovery program screens human neural stem cell lines for compounds that may stimulate neurogenesis in the brain, possibly reversing pathologies associated with certain CNS conditions. The company`s lead compound, NSI-189, has completed FDA Phase Ia and Ib safety trials for the treatment of major depressive disorder (MDD). Neuralstem is expecting to launch a Phase II study for MDD in 2015. Neuralstem`s first stem cell therapy product, NSI-566, a spinal cord-derived neural stem cell line, is in ongoing clinical trials to treat amyotrophic lateral sclerosis (ALS, or Lou Gehrig`s disease), for which it has received orphan status designation by the FDA. Dosing in a phase IIa trial was completed in July, 2014. The next trial is anticipated to commence in 2015. In addition to ALS, the company is conducting an NSI-566 Phase I trial in chronic spinal cord injury, with NSI-566 clinical development also underway to treat ischemic

Planned Parenthood Alhambra Health Center

Planned Parenthood Alhambra Health Center is a Alhambra, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SynteractHCR

SynteractHCR is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development.